Pfizer Prize honors Geneva scientists for tumor vaccine

A Geneva-based scientific trio has been awarded the prestigious Pfizer Prize for Biomedical Research for its tumor-stopping vaccine. There's still a long way to go before this promising product is brought to market, explains Nicolas Mach, one of the award-winning researchers.